TBC1D3I

Across TCGA pan-cancer cohorts, TBC1D3I Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated TBC1D3I data layer compared with 10 for mass-spec protein.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher TBC1D3I Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated TBC1D3I expression acts as an unfavorable survival marker.

LUAD are the cancer types where TBC1D3I Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Median	All	0.156	0.812	<.001	24	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

TBC1D3I–LUAD (OS)

Open the LUAD breakdown →